A jab that prevents type 2 diabetes by making obese people feel full has been developed by scientists that is claimed more than halves risk of the disease in overweight individuals.
A US team hailed the injection, which contains an appetite suppressing drug called semaglutide, as a "game changer". Lead author Dr Timothy Garvey, of the University of Alabama, said: "Semaglutide reduces the future risk of diabetes by over 60 per cent in patients with obesity. This figure is similar whether a patient has prediabetes or normal blood sugar levels.
"Given the rising rates of obesity and diabetes, semaglutide could be used effectively to reduce the burden of these chronic diseases." The medication, branded Wegovy, makes people feel fuller and not as hungry - so they eat less. Sustained treatment is required to maintain the benefit.
